KAMADA EACH LIFE IS UNIQUE Trademark
Trademark Overview
On Tuesday, August 12, 2025, a trademark application was filed for KAMADA EACH LIFE IS UNIQUE with the United States Patent and Trademark Office. The USPTO has given the KAMADA EACH LIFE IS UNIQUE trademark a serial number of 99333233. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, August 12, 2025. This trademark is owned by KAMADA LTD.. The KAMADA EACH LIFE IS UNIQUE trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals namely plasma derived and recombinant immunoglobulins; pharmaceuticals namely plasma derived and recombinant proteins for treating pulmonary diseases, congenital Alpha-1 Antitrypsin deficiency, post-exposure prophylaxis against viral infection, preventing and treating immune tolerance based diseases, treating immunological disorders and treating inflammatory diseases; pharmaceuticals namely coagulation factors for bleeding disorders; plasma-derived protein preparations for therapeutic use; vaccines; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for the treatment or prevention of thrombo-embolic disorders; pharmaceutical preparations for anesthesia analgesia for surgery; pharmaceutical preparations for treatment of CMV infection and disease; pharmaceutical preparations for the treatment of Varicella Zoster Virus; pharmaceutical preparations for treatment of Hepatitis; pharmaceutical preparations for the treatment of Rabies
General Information
| Serial Number | 99333233 |
| Word Mark | KAMADA EACH LIFE IS UNIQUE |
| Filing Date | Tuesday, August 12, 2025 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Tuesday, August 12, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceuticals namely plasma derived and recombinant immunoglobulins; pharmaceuticals namely plasma derived and recombinant proteins for treating pulmonary diseases, congenital Alpha-1 Antitrypsin deficiency, post-exposure prophylaxis against viral infection, preventing and treating immune tolerance based diseases, treating immunological disorders and treating inflammatory diseases; pharmaceuticals namely coagulation factors for bleeding disorders; plasma-derived protein preparations for therapeutic use; vaccines; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for the treatment or prevention of thrombo-embolic disorders; pharmaceutical preparations for anesthesia analgesia for surgery; pharmaceutical preparations for treatment of CMV infection and disease; pharmaceutical preparations for the treatment of Varicella Zoster Virus; pharmaceutical preparations for treatment of Hepatitis; pharmaceutical preparations for the treatment of Rabies |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 12, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, March 31, 2017 |
| First Use In Commerce Date | Friday, March 31, 2017 |
Trademark Owner History
| Party Name | KAMADA LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Rehovot 7670402
IL |
Trademark Events
| Event Date | Event Description |
| Tuesday, August 12, 2025 | NEW APPLICATION ENTERED |
| Tuesday, August 12, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 12, 2025 | APPLICATION FILING RECEIPT MAILED |
